Health regulators warn against the use or dispensing of recalled Semaglutide and Tirzepatide
Safety Classified by Officially
Pretoria, 08 July 2026 – The South African Pharmacy Council (SAPC), Health Professions Council of South Africa (HPCSA) and the South African Health Products Regulatory Authority (SAHPRA) hereby warn the public, pharmacies and dispensing medical practitioners against any continued use, prescription and/or dispensing of iDEXIS... …
This is an extract. The publication continues at the source.
Read the original at the source: https://www.sahpra.org.za/health-regulators-warn-against-the-use-or-dispensing-of-recalled-semaglutide-and-tirzepatide/ This address stopped responding when last checked on October 10, 2026. The record below is what Officially captured.
Officially imported this from SAHPRA’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- SAHPRA — imported from official source
- Official source
- https://www.sahpra.org.za/feed/ RSS
- Imported
- October 03, 2026 20:35
- Versions
- 1 recorded
- Identity
-
https://www.sahpra.org.za/?p=20020